[1] ALLUM WHL, STENNING SP, BANCEWICZ J, et al.Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J]. J Clin Oncol, 2009, 27(30):5062. doi: 10.1200/JCO.2009.22.2083
[2] 王玉祥, 杨琼, 何明, 等.Ⅲ期胸段食管鳞癌根治术后的复发规律[J].中华肿瘤杂志, 2017, 39(1):48
[3] ZHANG XB, YANG Y, SUN YF, et al.Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma[J]. J Thorac Dis, 2019, 11(6):2512. doi: 10.21037/jtd.2019.05.70
[4] NI W, CHEN J, XIAO Z, et al.Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma:results from a Chinese twoenter study[J]. Thorac Cancer, 2019, 10(5):1431.
[5] CHEN JQ, PAN JJ, ZHENG XW, et al.Number and location of positive nodes postoperative radiotherapy, and survival afteresophagectomy with three field lymph node dissection for thoracic esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2012, 82(1):475. doi: 10.1016/j.ijrobp.2010.08.037
[6] 贲晨, 赵伟, 黄克诚.经右胸食管癌切除术配合管状胃成形在食管癌治疗中的临床应用[J].蚌埠医学院学报, 2015, 39(7):938.
[7] LIU Q, CAI XW, FU XL, et al.Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma[J]. Oncotarge, 2015, 6(31):32220. doi: 10.18632/oncotarget.4730
[8] SHEN WB, WANG YF, GAO HM, et al.Dosimetric predictors of radiation gastritis due to postoperative intensity modulated irradiation therapy in patients with esophageal squamous cell carcinoma after radical esophagectomy[J]. Cancer Biother Radiopharm, 2019, 34(7):419. doi: 10.1089/cbr.2018.2743
[9] NAKAMURA AL, SHIBUYA K, MATSUO Y, et al.Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy[J]. Int J Radiat Oncol Biol Phys, 2012, 84(2):369. doi: 10.1016/j.ijrobp.2011.12.026